Copyright
©The Author(s) 2022.
World J Hepatol. Sep 27, 2022; 14(9): 1817-1829
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1817
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1817
Variable | Overall | Patients with palliative consult | Patients without palliative consult | P value |
Number of patients | 973246 | 47423 | 925823 | |
Patient characteristics | ||||
Female | 276401 (28.4%) | 14037 (29.6%) | 262933 (28.4%) | < 0.001 |
Age in yr | 54.7 ± 004 | 57.2 ± 0.1 | 54.5 ± 0.04 | < 0.001 |
Age divided into categories | ||||
18-35 | 36010 (3.7%) | 1327 (2.8%) | 33329 (3.6%) | < 0.001 |
36-45 | 108030 (11.1%) | 3604 (7.4%) | 103692 (11.2%) | < 0.001 |
46-65 | 625797 (64.3%) | 28975 (61.1%) | 595304 (64.3%) | < 0.001 |
> 66 | 204381 (21%) | 13136 (27.7%) | 191645 (20.7%) | < 0.001 |
Race | ||||
White | 660834 (67.2%) | 33433 (70.5%) | 614746 (66.4%) | < 0.001 |
Black | 96351 (9.9%) | 4647 (9.8%) | 95359 (10.3%) | < 0.001 |
Hispanic | 160585 (16.5%) | 6544 (13.8%) | 161093 (17.4%) | < 0.001 |
Other | 60341 (6.2%) | 2940 (6.2%) | 57401 (6.2%) | 0.532 |
Charleston comorbidity index | ||||
0 or 1 | 118736 (12.2%) | 2371 (5%) | 116653 (12.6%) | < 0.001 |
2 | 46715 (4.1%) | 948 (2%) | 38884 (4.2%) | < 0.001 |
3 or more | 854509 (87.8%) | 45051 (95%) | 809169 (87.4%) | < 0.001 |
Median income in patient zip code | ||||
$1–$38999 | 297813 (30.6%) | 13894 (29.3%) | 283301 (30.6%) | 0.003 |
$39000–$47999 | 255963 (26.3%) | 12946 (27.3%) | 245343 (26.5%) | 0.004 |
$48000–$62999 | 231632 (23.8%) | 11144 (23.5%) | 220345 (23.8%) | 0.133 |
> $63000 | 187836 (19.3%) | 9389 (19.8%) | 178683 (19.3%) | < 0.001 |
Insurance provider | ||||
Medicare | 341609 (35.1%) | 17878 (37.7%) | 328667 (35.5%) | < 0.001 |
Medicaid | 260829 (26.8%) | 12045 (25.4%) | 249046 (26.9%) | < 0.001 |
Private | 255963 (26.3%) | 12282 (25.9%) | 243491 (26.3%) | < 0.001 |
Uninsured | 114843 (11.8%) | 5216 (11%) | 109247 (11.8%) | < 0.001 |
Hospital characteristics | ||||
Teaching hospital | 514847 (52.9%) | 28690 (60.5%) | 486982 (52.6%) | < 0.001 |
Urban hospital | 891493 (91.6%) | 44387 (93.6%) | 847128 (91.5%) | < 0.001 |
Hospital region | ||||
Northeast | 177130 (18.2%) | 6828 (14.4%) | 170351 (18.4%) | < 0.001 |
Midwest | 199515 (20.5%) | 9911 (20.9%) | 189793 (20.5%) | 0.832 |
South | 345502 (35.5%) | 16692 (35.2%) | 328667 (35.5%) | 0.104 |
West | 251097 (25.8%) | 13989 (29.5%) | 237010 (25.6%) | < 0.001 |
Hospital size | ||||
Small | 122628 (12.6%) | 4931 (10.4%) | 118505 (12.8%) | < 0.001 |
Medium | 258883 (26.6%) | 12756 (26.9%) | 246268 (26.6%) | 0.002 |
Large | 590760 (60.7%) | 29734 (62.7%) | 561048 (60.6%) | < 0.001 |
Hospital complications | ||||
Variceal bleed | 114843 (11.8%) | 4789 (10.1%) | 110428 (11.9%) | < 0.001 |
HRS | 22619 (7.2%) | 14942 (23.8%) | 75917 (8.2%) | < 0.001 |
Hepatic encephalopathy | 321171 (33%) | 24375 (51.4%) | 322186 (34.8%) | < 0.001 |
Ascites | 605359 (62.2%) | 34191 (72.1%) | 565677 (61.1%) | < 0.001 |
SBP | 23357 (2.4%) | 1659 (3.5%) | 21293 (2.3%) | < 0.001 |
Hepatocellular carcinoma | 60341 (6.2%) | 5927 (12.5%) | 49994 (5.4%) | < 0.001 |
NACSELD-ACLF score | ||||
0 | 495382 (50.9%) | 11191 (23.6%) | 482353 (52.1%) | < 0.001 |
1 | 389298 (40%) | 22810 (48.1%) | 366625 (39.6%) | < 0.001 |
2 | 64234 (6.6%) | 8536 (18%) | 56475 (6.1%) | < 0.001 |
3 | 22384 (2.3%) | 4505 (9.5%) | 18516 (2%) | < 0.001 |
4 | 973 (0.1%) | 426(0.9%) | 925 (0.1%) | < 0.001 |
ACLF ≥ 2 | 89538 (9.2%) | 13420 (28.3%) | 76843 (8.3%) | < 0.001 |
Mean ACLF score | 0.64 | 1.21 | 0.61 | < 0.001 |
Variable | Adjusted odds ratio | 95%CI | P value |
Age | 1.02 | 1.00-1.04 | < 0.001 |
Median income in patient zip code | |||
$1-$38999 | Reference | ||
$39000-$47999 | 1.07 | 0.98-1.16 | 0.117 |
$48000-$62999 | 0.99 | 0.9-1.08 | 0.983 |
> $63000 | 0.95 | 0.85-1.02 | 0.141 |
Female sex | 1.07 | 1.00-1.14 | 0.023 |
Race | |||
Caucasian | Reference | ||
African Americans | 0.81 | 0.72-0.9 | < 0.001 |
Hispanic | 0.71 | 0.64-0.78 | < 0.001 |
Others | 0.89 | 0.78-1.00 | 0.069 |
Charleson comorbidity index | 1.1 | 1.08-1.12 | < 0.001 |
Insurance status | |||
Medicare | Reference | ||
Medicaid | 1.34 | 1.19-1.51 | < 0.001 |
Private insurance | 1.18 | 1.08-1.29 | < 0.001 |
Uninsured | 1.52 | 1.36-1.7 | < 0.001 |
Teaching hospital | 1.4 | 1.28-1.53 | < 0.001 |
Bed size | |||
< 250 beds | Reference | ||
251-400 beds | 1.24 | 1.09-1.42 | 0.001 |
> 400 Beds | 1.25 | 1.1-1.41 | < 0.001 |
Urban location | 0.96 | 0.83-1.19 | 0.625 |
Length of stay by groups | |||
< 3 d | Reference | ||
3-5 d | 0.92 | 0.84-1.00 | 0.065 |
> 5 d | 1.18 | 1.10-1.26 | < 0.001 |
Rehab transfer | 4.07 | 3.29-5.04 | < 0.001 |
ACLF Score | |||
1 | 2.53 | 2.35-2.71 | < 0.001 |
2 | 6.05 | 5.5-6.66 | < 0.001 |
3 | 9.86 | 8.75-11.1 | < 0.001 |
4 | 10.61 | 7.32-15.42 | < 0.001 |
ACLF ≥ 2 | 3.47 | 3.21-3.74 | < 0.001 |
Hepatocellular carcinoma | 1.78 | 1.58-2.00 | < 0.001 |
Infection | 1.58 | 1.48-1.69 | < 0.001 |
Mechanical ventilation | 3.32 | 3.1-3.54 | < 0.001 |
Total parenteral nutrition | 2.02 | 1.8-2.27 | < 0.001 |
Hepatorenal syndrome | 3.4 | 3.04-3.81 | < 0.001 |
Ascites | 1.13 | 1.03-1.24 | < 0.001 |
Spontaneous bacterial peritonitis | 3.34 | 2.65-3.86 | < 0.001 |
Age | 1.02 | 1.00-1.04 | < 0.001 |
Female sex | 1.07 | 1.00-1.14 | 0.023 |
Race | |||
Caucasian | Reference | ||
African Americans | 0.81 | 0.72-0.9 | < 0.001 |
Hispanic | 0.71 | 0.64-0.78 | < 0.001 |
Others | 0.89 | 0.78-1.00 | 0.069 |
Charleson comorbidity index | 1.1 | 1.08-1.12 | < 0.001 |
Insurance status | |||
Medicare | Reference | ||
Medicaid | 1.34 | 1.19-1.51 | < 0.001 |
Private insurance | 1.18 | 1.08-1.29 | < 0.001 |
Uninsured | 1.52 | 1.36-1.7 | < 0.001 |
Teaching hospital | 1.4 | 1.28-1.53 | < 0.001 |
Bed size | |||
< 250 beds | Reference | ||
251-400 beds | 1.24 | 1.09-1.42 | 0.001 |
> 400 Beds | 1.25 | 1.1-1.41 | < 0.001 |
Urban location | 0.96 | 0.83-1.19 | 0.625 |
Length of stay by groups | |||
< 3 d | Reference | ||
3-5 d | 0.92 | 0.84-1.00 | 0.065 |
> 5 d | 1.18 | 1.10-1.26 | < 0.001 |
Rehab transfer | 4.07 | 3.29-5.04 | < 0.001 |
ACLF ≥ 2 | 3.47 | 3.21-3.74 | < 0.001 |
Variable | Unadjusted odds ratio | 95%CI | P value | Adjusted odds ratio | 95%CI | P value |
Palliative care | 0.36 | 0.31-0.41 | < 0.001 | 0.35 | 0.31-0.41 | < 0.001 |
Patient characteristics | ||||||
Age | 0.99 | 0.99-0.99 | < 0.001 | 0.99 | 0.99-0.99 | < 0.001 |
Median income in patient zip code | ||||||
$1-$38999 | Reference | |||||
$39000-$47999 | 0.97 | 0.94-1.01 | 0.236 | |||
$48000-$62999 | 1 | 0.97-1.04 | 0.655 | |||
> $63000 | 1.02 | 0.99-1.06 | 0.133 | |||
Female sex | 1.01 | 0.99-1.04 | 0.188 | |||
Race | ||||||
Caucasian | Reference | |||||
African-Americans | 0.77 | 0.52-1.12 | 0.175 | |||
Hispanic | 0.93 | 0.65-1.34 | 0.721 | |||
Others | 0.76 | 0.47-1.24 | 0.282 | |||
Mean charlson comorbidity index | 1.04 | 1.03-1.04 | < 0.001 | 1.06 | 1.05-1.06 | < 0.001 |
Insurance status | ||||||
Medicare | Reference | |||||
Medicaid | 1.14 | 1.11-1.18 | < 0.001 | |||
Private insurance | 0.89 | 0.86-0.93 | < 0.001 | |||
Uninsured | 0.75 | 0.71-0.78 | < 0.001 | |||
ACLF ≥ 2 | 0.89 | 0.84-0.95 | 0.001 | 0.86 | 0.81-0.91 | < 0.001 |
Infection | 1.07 | 1.04-1.10 | < 0.001 | 1.09 | 1.07-1.13 | < 0.001 |
Hospital characteristics | ||||||
Teaching hospital | 1.05 | 1.02-1.05 | < 0.001 | 1.02 | 0.99-1.05 | 0.208 |
Bed size | ||||||
< 250 beds | Reference | |||||
251-400 beds | 1 | 0.95-1.06 | 0.723 | |||
> 400 Beds | 1.02 | 0.97-1.07 | 0.37 | |||
Rural location | 0.85 | 0.83-0.88 | < 0.001 | 0.86 | 0.81-0.91 | < 0.001 |
- Citation: Gupta K, Hans B, Khan A, Sohail SH, Kapuria D, Chang C. A retrospective study on use of palliative care for patients with alcohol related end stage liver disease in United States. World J Hepatol 2022; 14(9): 1817-1829
- URL: https://www.wjgnet.com/1948-5182/full/v14/i9/1817.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i9.1817